These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

782 related items for PubMed ID: 6215712

  • 1. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
    Tan KF, Chang CH.
    Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
    [No Abstract] [Full Text] [Related]

  • 2. What do we want from a bone-scanning agent?
    Fogelman I, Bessent RG.
    J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
    [No Abstract] [Full Text] [Related]

  • 3. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH, Holman BL.
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [Abstract] [Full Text] [Related]

  • 4. An audit of paediatric technetium-99m methylene diphosphonate bone scans.
    Fishwick NG, Krarup KC, Belton IP, Finlay DB.
    Br J Radiol; 1994 Jun; 67(798):552-5. PubMed ID: 8032808
    [Abstract] [Full Text] [Related]

  • 5. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
    Otsuka N, Yoneda M, Sawai M, Saito J, Nagai K, Muranaka A, Terashima H, Yanagimoto S, Ito Y.
    Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
    [No Abstract] [Full Text] [Related]

  • 6. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
    Abe M, Ohde R, Ogata T, Kawaguchi S, Kikuchi K, Kawai T, Matsuzawa K, Takanoshi H.
    Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
    [No Abstract] [Full Text] [Related]

  • 7. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
    Isobe Y, Ko S, Umegaki Y, Takahashi S, Kawaguchi N, Wada S, Matsumoto S.
    Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
    [No Abstract] [Full Text] [Related]

  • 8. Pitfalls of absent or faint kidney sign or bone scan.
    Constable AR, Cranage RW.
    J Nucl Med; 1981 Jul; 22(7):658. PubMed ID: 6454765
    [No Abstract] [Full Text] [Related]

  • 9. [An experimental crossover study between hydroxymethylene diphosphonate kit and methylene diphosphonate (author's transl)].
    Nagai K, Muranaka A, Otsuka N, Terashima H, Yanagimoto S, Nagase N, Ito Y.
    Radioisotopes; 1982 Jan; 31(1):32-4. PubMed ID: 6461888
    [No Abstract] [Full Text] [Related]

  • 10. [Evaluation of 113mIn-DTPMP and 99mTc-MDP for bone scanning].
    Yang JS.
    Zhonghua Fang She Xue Za Zhi; 1984 Feb; 18(1):58-62. PubMed ID: 6236062
    [No Abstract] [Full Text] [Related]

  • 11. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
    Okahashi S, Ishimaru T, Maeda H, Sakata T, Yamasaki K, Akagi H.
    Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
    [No Abstract] [Full Text] [Related]

  • 12. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
    Rudd TG, Allen DR, Smith FD.
    J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
    [Abstract] [Full Text] [Related]

  • 13. Brucellosis simulating metastases on Tc-99m MDP bone scan.
    Elgazzar AH, Abdel-Dayem HM, Shible O.
    Clin Nucl Med; 1991 Mar; 16(3):189-91. PubMed ID: 2032437
    [No Abstract] [Full Text] [Related]

  • 14. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G, McAfee JG, Thomas FD, Feld TA, Zapf-Longo C, Palladino E.
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [Abstract] [Full Text] [Related]

  • 15. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U, Kleinhans E, Zorn-Bopp E, Reuschel W, Muenzing W, Moser EA, Seiderer M.
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [Abstract] [Full Text] [Related]

  • 16. [Value and limitations of scintigraphy based on methylene diphosphonate pyrophosphate labeled with 99m technetium in the monitoring of revascularized bone transplants].
    Clouet M, Chavoin JP, Vigoni F, Pessey JJ, Costagliola M.
    Ann Chir Plast; 1981 Mar; 26(3):217-20. PubMed ID: 6458230
    [No Abstract] [Full Text] [Related]

  • 17. [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases].
    Hotze A, Löw A, Mahlstedt J, Wolf F.
    Rofo; 1984 Jun; 140(6):717-23. PubMed ID: 6234628
    [Abstract] [Full Text] [Related]

  • 18. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent].
    Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr 25; 42(4):389-97. PubMed ID: 6214765
    [No Abstract] [Full Text] [Related]

  • 19. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G, Durez M, Bevilacqua M, Abramovici J, Robience Y.
    Clin Nucl Med; 1986 Feb 25; 11(2):92-7. PubMed ID: 3769350
    [Abstract] [Full Text] [Related]

  • 20. Labeling efficiency and stomach concentration in methylene diphosphonate bone imaging.
    Dhawan V, Yeh SD.
    J Nucl Med; 1979 Jul 25; 20(7):791-3. PubMed ID: 541718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.